Atlas FDA

INTERSTIM THERAPY FOR URINARY CONTROL

FDA premarket approval P970004/S153 · decided 2014-04-15

Approval details

PMA number
P970004
Supplement
S153
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Labeling Change - PAS
Trade name
INTERSTIM THERAPY FOR URINARY CONTROL
Generic name
Stimulator, electrical, implantable, for incontinence
Applicant
Medtronic Neuromodulation
Date received
2013-03-07
Decision date
2014-04-15
Days to decision
404 days
Decision code
APPR
Product code
EZW
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Minneapolis, MN
Statement
APPROVAL FOR LABELING UPDATES TO INCORPORATE THE LONG-TERM DATA FROM THE FECAL INCONTINENCE POST-APPROVAL STUDY INTO THE INTERSTIM THERAPY LABELING.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
SureTune4 Software (DEN210003)Medtronic Neuromodulation2021-08-23